Drug Index

HUMIRA

Generic: ADALIMUMAB

Review priority: STANDARD Marketing status: Prescription

Route: SYRINGE
Class: General Medications
Safety profile: routine
Latest regulatory update: 23 Dec 2025, 12:00 am (UTC)

Structured Monograph

Approval overview HUMIRA is listed in Drugs@FDA under application 125057 (BLA). Review priority: STANDARD Marketing status: Prescription Active ingredient ADALIMUMAB Form and strength SYRINGE - 40MG/0.8ML Sponsor ABBVIE INC Submission history Latest submission status date: 2025-12-23 00:00:00. Submission type: SUPPL.